Final Results of the RHAPSODY Trial: A Multi‐Center, Phase 2 Trial Using a Continual Reassessment Method to Determine the Safety and Tolerability of 3K3A‐APC, A Recombinant Variant of Human Activated…

Overview of attention for article published in Annals of Neurology, January 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#24 of 6,674)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 57 news outlets
blogs: 4 blogs
twitter: 24 X users

wikipedia: 1 Wikipedia page
reddit: 1 Redditor

Readers on

mendeley: 139 Mendeley

So far, Altmetric has seen 5 posts from 4 blogs.

Star USC scientist faces scrutiny — retracted papers and a paused drug trial

Picture of Health - baltimoresun.com, 25 May 2024

Corinne Purtill | Los Angeles Times (TNS) LOS ANGELES — Late last year, a group of whistle-blowers submitted a report to the…

Schneider Shorts 17.11.2023 – This brilliant scientist has been punished enough

For Better Science, 17 Nov 2023

Schneider Shorts 17.11.2023 - a sexual harasser comes to Prague, cover-ups in London and Florence, with a Dutch scam, many…

Stroke drug shows promise in treating Alzheimer’s and dementia

ScienceBlog.com, 10 Dec 2021

Ahuman stroke drug, fast-tracked by the Food and Drug Administration and soon entering Phase 3 clinical trials, shows…

Stroke drug might also prove a powerful tool against dementia

Science Blog, 02 Dec 2021

A human stroke drug, fast-tracked by the Food and Drug Administration and soon entering Phase 3 clinical trials, shows…

This page shows the most recent blog posts that mention this research output. Click here to find out how to access more activity, including 1 additional blog posts.